Skip to main content
. Author manuscript; available in PMC: 2015 Jan 22.
Published in final edited form as: J Cardiovasc Pharmacol. 2010 Mar;55(3):234–239. doi: 10.1097/FJC.0b013e3181ce5e14

Figure 1. Experimental protocols.

Figure 1

Protocol A was used for all inotropy and signaling studies. Ouabain was perfused at 100 or 500 nM for 20 min. Protocol B was used for preconditioning studies. Ouabain was given for 4 min at the dose of 100 nM, as indicated. After ischemia, all hearts were reperfused with standard Krebs-Henseleit buffer for 2 hours.